Skip to main content

Market Overview

Morning Market Losers

Share:

Bellerophon Therapeutics Inc (NASDAQ: BLPH) shares tumbled 57.52 percent to $3.25 after the company reported top-line results from its PRESERVATION I clinical trial for Bioabsorbable Cardiac Matrix.

Republic Airways Holdings Inc. (NASDAQ: RJET) shares fell 36.53 percent to $5.39 as the company reported preliminary second quarter 2015 results on Friday. The company projected Q2 net income of $0.08 to $0.10 per share, on operating revenue of $338 to $340 million. Deutsche Bank downgraded Republic Airways Holdings from Buy to Hold and lowers the price target from $15.00 to $9.00.

Bioline RX Ltd (NASDAQ: BLRX) dropped 26.89 percent to $1.55 after the company confirmed negative top-line results from Bellerophon's PRESERVATION I clinical trial for Bioabsorbable Cardiac Matrix.

Mylan NV (NASDAQ: MYL) shares dipped 14.39 percent to $56.45. Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced its plans to buy Allergan PLC's (NYSE: AGN) generic drugs unit for $40.5 billion in a cash and stock deal. Teva also reported that it has dropped its $40 billion cash and stock bid for Mylan.

SFX Entertainment Inc (NASDAQ: SFXE) slipped 11.66 percent to $3.41. Stifel Nicolaus downgraded SFX Entertainment from Buy to Hold.

Noah Holdings Limited (ADR) (NYSE: NOAH) dropped 11.50 percent to $20.71. Noah Holdings is expected to announce Q2 financial results on Monday, August 3, 2015.

Weibo Corp (ADR) (NASDAQ: WB) shares slipped 9.19 percent to $13.15 after falling 2.95 percent on Friday.

JD.Com Inc(ADR) (NASDAQ: JD) shares dropped 5.37 percent to $32.78 after slipping 0.17 percent on Friday.

 

Related Articles (RJET + BLPH)

View Comments and Join the Discussion!

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com